Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza

NCT00453999 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: Peramivir 200 mg
DRUG: Peramivir 400 mg
DRUG: Oseltamivir

Sponsor

BioCryst Pharmaceuticals